SESN2 and Parkinson disease: In PD models, SESN2 upregulation triggers a reduction in neurotoxicity (107) and an autophagic response, preventing α-synuclein expression, apoptotic caspase-3 activation, and cytotoxicity in dopaminergic cells (108).